ORPHARMA'S dispersible tablet Udicane (carglumic acid) has been designated orphan drug status for treatment of hyperammonaemia under specific conditions.
Visit www.tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Oct 16